PAVmed Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
PAVM Nasdaq 3841 www.pavmed.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for PAVmed Inc.

Lucid Diagnostics Recognized as a GenomeWeb Best Place to Work for Second Consecutive Year - Nov 5th, 2026 6:25 am
Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum - Nov 4th, 2026 6:55 am
Lucid Diagnostics Announces Publication of Landmark 12,000-Patient Real-World EsoGuard® Study - Nov 3rd, 2026 6:15 am
PAVmed to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 13, 2026 - Oct 30th, 2026 6:30 am
Lucid Diagnostics to Hold Third Quarter 2026 Business Update Conference Call and Webcast on November 12, 2026 - Oct 29th, 2026 6:30 am
Lucid Diagnostics Begins Receiving Medicare Reimbursement for EsoGuard® and Closes $15 Million Financing - Oct 22nd, 2026 2:20 pm
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways - Sep 22nd, 2026 5:55 am
PAVmed (PAVM) Q2 2026 Earnings Call Transcript - Aug 14th, 2026 6:58 pm
PAVmed Inc (PAVM) (Q2 2026) Earnings Call Highlights: Narrowing Losses and Strategic Progress ... - Aug 14th, 2026 5:02 pm
PAVmed Inc. Q2 2026 Earnings Call Summary - Aug 14th, 2026 2:59 pm
PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results - Aug 14th, 2026 6:00 am
Lucid Diagnostics Provides Business Update and Reports Second Quarter 2026 Financial Results - Aug 13th, 2026 6:00 am
Lucid Diagnostics Secures Commercial Coverage Policy Spanning Multiple Health Plans for its EsoGuard® Esophageal DNA Test - Aug 5th, 2026 6:36 am
Lucid Diagnostics to Participate in Upcoming Investor Conferences - Aug 4th, 2026 6:30 am
PAVmed to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 14, 2026 - Jul 31st, 2026 6:30 am
Lucid Diagnostics to Hold Second Quarter 2026 Business Update Conference Call and Webcast on August 13, 2026 - Jul 30th, 2026 6:30 am
How The PAVmed (PAVM) Narrative Is Shifting With Reworked Assumptions And A Lower Price Target - Jun 1st, 2026 2:12 am
PAVmed Inc. Q1 2026 Earnings Call Summary - May 16th, 2026 6:30 am
PAVmed Inc (PAVM) Q1 2026 Earnings Call Highlights: Strategic Restructuring and Growth ... - May 15th, 2026 5:01 pm